chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Da of Vaccine-1/11/21-at about 7:00 pm in the evening employee started having nausea, left arm (vaccine arm) pain, all left side pain and numbness down to left foot, fever 99-100, diarrhea, joint soreness, stomach cramps.  Day 2-1/12/21-headache, diarrhea, left side all felt heavy, left arm remained sore and limited ROM in left arm.  Day 3-1/13/21-Mild diarrhea only and on Day 4 1/14/21-nothing, all symptoms gone.
VACCINE WAS REFROZEN; ADMINISTRATION OF REFROZEN VACCINE; This spontaneous report received from a health care professional concerned a 53 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A31A expiry: UNKNOWN) dose was not reported, administered on 24-NOV-2021 for prophylactic vaccination. Age at time of vaccination 53 years old. No concomitant medications were reported. On 24-NOV-2021, the patient experienced administration of refrozen vaccine. On an unspecified date, the patient experienced vaccine was refrozen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of refrozen vaccine and vaccine was refrozen was not reported. This report was non-serious. This case, from the same reporter is linked to 20220537683, 20220537548, 20220538428, 20220538297, 20220539045, 20220538425, 20220537688, 20220538379, 20220537507, 20220538627, 20220537341, 20220538437, 20220537444, 20220538292, 20220538347, 20220538411, 20220538693, 20220539045, 20220538146, 20220538316, 20220538210, 20220538758, 20220538238, 20220538480, 20220538149, 20220538666, 20220540435 and 20220540524.
This case was reported by a pharmacist, via Merck, and described the occurrence of anaphylactic reaction in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of TWINRIX (details unknown). At an unspecified time after vaccination with TWINRIX, the subject experienced anaphylactic reaction. The pharmacist reported that an unspecified patient experienced an anaphylactic reaction after receiving TWINRIX at an unspecified time. No further information was available. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the event was unspecified.
Information has been received from a physician concerning a 28 month old male who on 10/29/2001 was vaccinated with the first dose of varicella vaccine in the right thigh. Concomitant therapy included hep A vaccine. Subsequently, 10 days later, the pt developed a widespread pox rash throughout the gluteal area with 100 lesions present. The pt was treated with Zovirax po. The physician reported that he has collected isolates for analysis for diagnosis of varicella va. VZVID. Additional info has been received from the physician. The physician reported that on 11/13/2001 the pt developed an acute localized vesicular rash on his right anterior thigh crease that was diagnosed as shingles. In November a viral culture of a vesicle was negative for varicella. The physician reported that the pt recovered. No additional info is expected.
We discovered that the patient was 17 after the vaccine was already administered. The recommended age for the Moderna vacine is 18.
Pt was inadvertently given 1ml of FLUZONE instead of correct 0.5 ml dose. Pt reported no skin reaction and no adverse events
Numbness; Poufy Cheeks; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness) and SWELLING FACE (Poufy Cheeks) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness) and SWELLING FACE (Poufy Cheeks). At the time of the report, HYPOAESTHESIA (Numbness) and SWELLING FACE (Poufy Cheeks) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Fever 100 degrees, headache, fatigue. Fever resolved with one dose Tylenol 650mg & headache improved slightly. Headache resolved the next day after one dose  Motrin 400mg. Fatigue resolved on day two.
This spontaneous report has been received from the patient's mother via a social media refers to a 17 year old female patient. On an unknown date the patient was vaccinated with GARDASIL (dose, route and frequency were not reported, lot# was unknown). The reporter reported his daughter had a serious adverse reaction to the GARDASIL vaccine and needed urgent care at a local hospital. The outcome of the serious severe adverse reaction was not reported. This is one of the several reports from the same social media. Additional information has been requested.
This case was reported by a other health professional via sales rep and described the occurrence of pain in a 61-year-old female patient who received SHINGRIX (batch number L7SY9, expiry date 4th July 2021) for prophylaxis. The patient's past medical history included paralysis (left side). Previously administered products included SHINGRIX (On 15th November 2018, 1st dose received in left deltoid, batch number 424A7 and expiry date 18th April 2021). Concurrent medical conditions included multiple sclerosis. On 19th February 2019, the patient received the 2nd dose of SHINGRIX. In February 2019, less than a day after receiving SHINGRIX, the patient experienced pain (serious criteria hospitalization), back pain (serious criteria hospitalization), immobile (serious criteria GSK medically significant), headache and performance status decreased. On an unknown date, the outcome of the pain, back pain, immobile, headache and performance status decreased were unknown. It was unknown if the reporter considered the pain, back pain, immobile, headache and performance status decreased to be related to SHINGRIX. Additional details were provided as follows: The patient had multiple scerlosis and was in a motorized chair. The patient received SHINGRIX in left deltoid. There were no reaction from 1st dose. In night on the day of vaccination, the patient called the offices after hours and spoke to one of their providers. The patient complained of mild headache, and back pain increasing to 9 out of 10, no other symptoms besides severe pain, causing her not to be able to function. The patient was advised if got worse to call 911, mentioning everything hurts. On 19th February 2019, that night patient experienced so much pain she could not move, patient called 911 and went to the emergency room. The patient was admitted to hospital and was still there on day of reporting. The reporter agreed to follow up from GlaxoSmithKline.
Information has been received from a nurse concerning a 4 year old white female who on 03APR2000 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 31AUG2003 the patient developed a rash and was seen by a physician. She was diagnosed with a mild case of chickenpox. No laboratory work was done. the patient recovered on 05SEP2003. Additional information has been requested.
Mother reported tremors 2-3 hr after receiving vaccines. Patient was seen the next day in office. Tremors were observed but resolved in the course of one week.
Red, warm to touch, raised area, slightly swollen and itchy on left arm where injection was given.
serve cramping; having irregular periods and clotting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21May2021 05:15 (Lot number: 169) at the age of 25 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose number=1, product=COVID 19, lot unknown=True.), for COVID-19 immunisation. The following information was reported: DYSMENORRHOEA (non-serious) with onset 01Jun2021, outcome "not recovered", described as "serve cramping"; MENSTRUATION IRREGULAR (non-serious) with onset 01Jun2021, outcome "not recovered", described as "having irregular periods and clotting". The events "serve cramping" and "having irregular periods and clotting" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of dysmenorrhoea, menstruation irregular.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. She had irregular periods and clotting this has never happened to her and been having periods for 15 years. This did not start until she got the shot. And serve cramping she was in the Army and cannot have complications like this. No treatment was given for the events. The patient did not experienced covid prior vaccination. The patient did not experienced covid post vaccination. Patient did not have any known allergies.  No follow-up attempts are possible. No further information is expected.
stuffy nose; coughing; increase in temperature; body aches; This case was reported by a consumer via call center representative and described the occurrence of nasal stuffiness in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number 93FR9, expiry date 29th April 2022) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE (FLUAD) (batch number 279811, expiry date 30th June 2021) for prophylaxis.   On 8th October 2020, the patient received the 1st dose of Shingrix (intramuscular) and FLUAD (intramuscular). In October 2020, 20 hrs after receiving Shingrix, the patient experienced nasal stuffiness, cough, body temperature increased and general body pain. On an unknown date, the outcome of the nasal stuffiness, cough, body temperature increased and general body pain were not recovered/not resolved.   It was unknown if the reporter considered the nasal stuffiness, cough, body temperature increased and general body pain to be related to Shingrix.  Additional details were reported as follows: On 8th October 2020, at 1 pm in the right arm the patient received Shingrix and Fluad vaccine in the left arm at the same time and on 9th October 2020 20 hours after vaccines had body aches, increase in temperature by 1 degree, coughing and stuffy nose.  At the time of reporting events was still ongoing but were minor. It was unknown if the reporter considered the nasal stuffiness, cough, body temperature increased and general body pain to be related to FLUAD. The reporter consented to follow up.
Fatigue, Hot and cold body temperature, chills, dizziness, flighty-light headed, night sweats, stomach and back pain
Headache, HYPERtension, neck stiffness, left arm weakness, Narrative: individual states having these symptoms all the time, almost resolved when left with husband driving home
High fever. Severe rash from bottom of elbow to neck. Severe swelling. Temperature of skin about 103 degrees. Broke out in welts. Wheezing problems. Pain. Itching.
Vomiting morning after vaccine x 1 resulting in periorbital petechiae. Puny, very sleepy and energyless Sat am. Large swelling and erythematous local rxn at (R) deltoid, arm (upper).
Itching on day one (6/19) then she woke up this morning with extreme swelling in the right deltoid and hot to the touch, still really itchy also.
I got my booster shot and had normal symptoms that Friday and Saturday nights. But Sunday morning, I felt swelling in my tonsils. I had difficulty swallowing and going down the esophagus, I had pain in my chest when eating because my throat as well. The next day, my gums were swelling and eating was so uncomfortable. I called my PCP and went in for an exam on 01/06/2022 and my doctor informed me the booster shot triggered an inflammatory response and caused all of the inflammation and swelling in my digestive system. I was given Valacyclovir and Omeprazole to help reduce the inflammation. I also got a COVID-19 PCR test and awaiting my results on that.
Patient came in for Moderna (1/2 dose) booster at 3:40 pm. The pharmacist administered the shot. Immediately after the shot was administered, the patient fainted and hit his head on the carpeted flooring. Patient gained consciousness immediately after fainting and bruised his head. An ice pack and water bottle were given to the patient. EMS was called to assess patient. Patient stated he felt fine and refused treatment from EMS.
He stated that after receiving their second Pfizer Covid-19 booster, they have chills and feel exhausted; He stated that after receiving their second Pfizer Covid-19 booster, they have chills and feel exhausted; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group.  A female patient received BNT162b2 (BNT162B2), on 03Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; unknown manufacturer), for COVID-19 Immunization; Comirnaty (Dose 3, booster), for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious), CHILLS (non-serious) all with onset 2022, outcome "unknown" and all described as "He stated that after receiving their second Pfizer Covid-19 booster, they have chills and feel exhausted". Additional information: Reporter also mentioned that he and his wife were at the doctor's office all day. He was told by the doctor that people can feel like they have COVID after receiving the vaccine. He stated that after receiving their second Pfizer Covid-19 booster, they have chills and feel exhausted. He is not happy with Pfizer right now.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200826843 same reporter, vaccine, event with different patients;
(L) deltoid with 5 x 6 cm erythema, induration and mild pain. No fever.
Patient was given the 2nd Pfizer vaccine 6 days before the recommended time between the 1st and 2nd dose
Child broke out in hives all over the body which lasted for 3 days. She was seen by the administering pediatrician for evaluation.
This spontaneous report has been received from an other health professional referring to multiple unspecified patients of unknown age and gender. On unknown dates the patients was vaccinated with doses of improperly stored VARIVAX (Merck) (lot # L002215, expiration date 21-JAN-2017 or lot# L013824, expiration date 21-APR-2017). These doses of vaccine had been exposed under temperature 27F for 4 hours. No adverse effects were reported. Additional information has been requested.
Immediate pain at the injection site, less than with the first dose.  12 hours later at 4:30am 3/26/21. I woke up with a fever of 99.9, extreme body aches, skin hurt to touch, horrible headache, bad arm pain, wasn't able to sleep much after that due to all of the pain.  Got up at 8am but in too much pain and went back to bed. Fever continued all day and fluctuated between 99.9 to 101.6.  Headache, body aches, joint pain, arm pain was so intense I couldn't get comfortable lying down but could not stand very long and couldn't sit up due to extreme fatigue.  Headache, body aches and joint pain started to diminish enough that I could sit up around 8:00pm 3/26/21.  Showered at 8:00pm. Ate at 9:00pm. In bed again by 11:00pm with fever at last check 99.9. Woke up to fever breaking at 1:00am 3/27/21  Slept through the night without waking up due to pain.  Woke up at 8am 3/27/21 some low grade fatigue but not in pain, no headache, and no fever. Feeling wiped out, arm still tender but not painful, feeling pretty great all things considered.  Will likely have an autoimmune reaction/flare, but when I get sick or get a vaccine it usually comes a few days after.
CHRONIC MIGRAINE; VISUAL DISTURBANCE/AFFECTED VISION; BAD NOSE BLEED; LOW FEVER; NAUSEA; This spontaneous report received from a patient concerned a 37 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included stevens johnson syndrome from med. The patient was previously treated with macrogol 4000. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported an has been requested. No concomitant medications were reported. On 10-APR-2021, the subject experienced low fever. On 10-APR-2021, the subject experienced nausea. On 17-APR-2021, the subject experienced bad nose bleed. On an unspecified date, the subject experienced chronic migraine, and visual disturbance/affected vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chronic migraine, low fever, nausea, bad nose bleed and visual disturbance/affected vision was not reported. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as case assessed as non serious.
Painful, warm, bruised swelling red rash wrapped underneath arm (not at injection site), started day of reception and continued for 3+ days. Patient was unaffected, but daughter was concerned.
Onset of severe nausea, h/a, generally not feeling well; 4-5hrs p/inject given lasting 24-30hrs;
stroke; his artery is totally blocked, blocked artery in his neck to the brain; his artery is totally blocked, blocked artery in his neck to the brain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, Pfizer COVID-19 Vaccine), for COVID-19 immunisation; Bnt162b2 (Dose 2, single, Pfizer COVID-19 Vaccine), for COVID-19 immunisation. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "stroke"; CAROTID ARTERY OCCLUSION (medically significant), CEREBRAL ARTERY OCCLUSION (medically significant), outcome "unknown" and all described as "his artery is totally blocked, blocked artery in his neck to the brain".  Clinical course: Reporter mentioned that she and her husband already got the 3 shots of Pfizer COVID-19 Vaccine and she mentioned that her husband experienced a stroke, and they want to know the if the Pfizer shot instigated some of it and they are calling to ask, what was the legal status on this. If the vaccine instigated this situation and must find out what was the legal status. She also mentioned that they have 3 authorities in their family and there was so much to get into the legal history right now. So, they are just reporting this stroke that her husband experienced, and also mentioned that he got block, his artery was totally blocked, blocked artery in his neck to the brain that is why he experienced stroke. Appropriate response could not be provided as the Reporter hung up the call abruptly. Call back was done, however reporter did not responded over the call. Thus, further probing could not be done. Hence, limited information available over the call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 12/2/13 she started crying when being fed; she was observed by her mom to be doing "weird things" with her eyes; 1/2 open, 1/2 closed, rolling back in her head; purple lips; in the office she was febrile 100.4 degrees F - this was not observed at home.
21 year patient inadvertentaly received pediatric dose of Engerix-B; 21 year patient inadvertentaly received pediatric dose of Engerix-B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 21-year-old female patient who received HBV (Engerix B pediatric) (batch number FB9RH, expiry date 31-JAN-2024) for prophylaxis.   On 31-AUG-2023, the patient received Engerix B pediatric. On 31-AUG-2023, an unknown time after receiving Engerix B pediatric, the patient experienced accidental underdose (Verbatim: 21 year patient inadvertentaly received pediatric dose of Engerix-B) and adult use of a child product (Verbatim: 21 year patient inadvertentaly received pediatric dose of Engerix-B).  The outcome of the accidental underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 31-AUG-2023 The reporter was a medical assistant. The reporter reported that the 21 years old patient inadvertently received pediatric dose of Engerix-B in the office, which led accidental underdose and adult use of a child product. The vaccine administration facility was the same as primary reporter. The medical assistant intended to gave another pediatric dose according to guidance.  No further details provided on call. The reporter consented to follow up.
PROQUAD given 8/4/11 - call ofc 8/16/11 to advise us her son may have had a reaction to vaccine. Stated pt had hives on thighs, arms & shoulder, & also had low grade fever 100.5 acting a bit lethargic & now seems fine. Sx's start 8/13/11.
Pain in arm shooting down to fingers.  Pain arthritic and moved around to forearm.  Very painful.  Still in pain after one month of receiving this shot in fingers and forearm.
Body ache, fever, burning eyes, watery eyes, sore throat, headache, nausea, dizziness, red welt on the vaccination area of ??the arm.
At this point She has large hives all over her body.  The first day was on her extremities.  Swollen hands and feet.  Each day produces more hives on more places in her body and she is itchy all the time.  As per the doctor, zyrtec every day and as of 1/6 started steroids.  The hives fluxuate  and are worst in the morning and at night.  I am being told that I need to monitor her and if she begins to have respiratory problems to take her to the emergency room. Otherwise, there is nothing they can do other than steroids.
Macular degeneration; This is a spontaneous report from a Pfizer Sponsored contactable consumer reported for herself. This female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unspecified date for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient had a second dose schedule on Tuesday. The patient needed to see her eye doctor prior to her second dose because of macular degeneration and she would have an injection on her eye. Patient was asking if this would be fine to have the injection before the vaccine. The outcome of event was unknown.  Information on the lot/batch number has been requested.